Upcoming CDER Workshops and Conferences

Upcoming CDER Meetings and Conferences Find details and additional offerings on CDER's Meetings, Conferences, & Workshops (Drugs) webpage. December Dec. 4, CDER SBIA Webinar: SEND for CBER, What You Need to Know Dec. 8, Drug Supply Chain Security Act pilot project program and enhanced drug distribution security Dec. 11, Evaluating the Effect of the Opioid Analgesics Risk Evaluation and Mitigation Strategy Education Program on Prescribing Behaviors and Patient Outcomes--Exploring the Path Forward for Assessment Dec. 14, Webinar: Update on FDAs Oncology Expanded Access Program, Project Facilitate. Dec. 15, Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting Dec. 16, Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting Dec. 16, Webinar: Diversity in Clinical Trials: Learn about Enrollment Trends and Resources from FDA January Jan. 14, 2021, CDER Compliance Conference Jan. 26, 2021, Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling March Mar. 3-4, 2021, Drug Master File (DMF) and Drug Substance Workshop Mar. 8, 2021, Public Meeting on Patient-Focused Drug Development for Vitiligo Recent Additions to SBIA Learning Library on YouTube Conferences Advancing Innovative Science in Generic Drug Development Workshop Webinars Guidance for Industry: Referencing Approved Drug Products in ANDA Submissions Promoting Safe and Effective Prescription Drug Use in Geriatric Patients FDA Announces Quality Management Maturity Programs The Small Business and Industry Assistance program in the Center for Drug Evaluation and Research (CDER SBIA) provides guidance, education and regular updates for regulated industry. Register for Upcoming Training Watch Learning Library Recordings on YouTube Subscribe to CDER SBIA Email Updates Follow on LinkedIn This is an automated message delivery system. Replying to this message will not reach the CDER SBIA staff. If you have comments or questions, contact us at CDERSBIA@fda.hhs.gov or 1-866-405-5367 or (301) 796-6707. Stay Connected with U.S. Food and Drug Administration:        SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA